Leading players profiled in this report:
• Koninklijke DSM N.V. (the Netherlands)
• BASF SE (Germany)
• Cyanotech Corporation (US)
• Otsuka Holdings Co. Ltd. (Japan)
• Divi’s Laboratories Ltd. (India)
• Valensa International (US)
• Fuji Chemical Industries Co. Ltd. (Japan)
• Beijing Gingko Group (China)
• Cardax, Inc. (Denmark)
• Piveg, Inc. (US)
• Fenchem Biotek Ltd. (China)
• Algatech Ltd. (Israel)
• Supreme Biotechnologies (New Zealand)
• Igene Biotechnology Inc. (US)
• Algamo (Czech Republic)
• Biogenic Co., Ltd. (Japan)
• Astamaz NZ Ltd. (New Zealand)
• Algalif (Iceland)
• Algae to Omega (US)
• Algae Health Sciences, Inc. (US)
• Koninklijke DSM N.V. (the Netherlands)
• BASF SE (Germany)
• Cyanotech Corporation (US)
• Otsuka Holdings Co. Ltd. (Japan)
• Divi’s Laboratories Ltd. (India)
• Valensa International (US)
• Fuji Chemical Industries Co. Ltd. (Japan)
• Beijing Gingko Group (China)
• Cardax, Inc. (Denmark)
• Piveg, Inc. (US)
• Fenchem Biotek Ltd. (China)
• Algatech Ltd. (Israel)
• Supreme Biotechnologies (New Zealand)
• Igene Biotechnology Inc. (US)
• Algamo (Czech Republic)
• Biogenic Co., Ltd. (Japan)
• Astamaz NZ Ltd. (New Zealand)
• Algalif (Iceland)
• Algae to Omega (US)
• Algae Health Sciences, Inc. (US)